Thrivent Financial For Lutherans Laboratory Corp Of America Holdings Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $15.4 Million - $17.2 Million	73,853 Added 9.48%	853,015 $186 Million
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $162,303 - $186,605	821 Added 0.11%	779,162 $177 Million
Q3 2023 Nov 14, 2023	BUY	$201.05 - $221.7 $12.5 Million - $13.7 Million	61,943 Added 8.65%	778,341 $156 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $25 Million - $28.4 Million	117,776 Added 19.67%	716,398 $173 Million
Q1 2023 May 17, 2023	SELL	$213.32 - $257.83 $4.32 Million - $5.23 Million	-20,269 Reduced 3.28%	598,622 $137 Million
Q4 2022 Feb 08, 2023	SELL	$203.72 - $248.97 $41.5 Million - $50.8 Million	-203,942 Reduced 24.79%	618,891 $146 Million
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $14.9 Million - $19 Million	-72,600 Reduced 8.11%	822,833 $169 Million
Q2 2022 Aug 16, 2022	BUY	$213.86 - $277.87 $187 Million - $243 Million	873,443 Added 3972.0%	895,433 $210 Million
Q1 2022 May 13, 2022	BUY	$259.82 - $298.18 $270,472 - $310,405	1,041 Added 4.97%	21,990 $5.8 Million
Q4 2021 Feb 16, 2022	SELL	$271.6 - $314.21 $181,428 - $209,892	-668 Reduced 3.09%	20,949 $6.58 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $32,703 - $36,692	-119 Reduced 0.55%	21,617 $6.08 Million
Q2 2021 Aug 19, 2021	BUY	$251.87 - $278.14 $6,296 - $6,953	25 Added 0.12%	21,736 $6 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $182,343 - $226,976	-890 Reduced 3.94%	21,711 $5.54 Million
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $2.24 Million - $2.57 Million	-11,982 Reduced 34.65%	22,601 $4.6 Million
Q3 2020 Nov 10, 2020	SELL	$167.03 - $201.3 $401,540 - $483,925	-2,404 Reduced 6.5%	34,583 $6.51 Million
Q2 2020 Aug 12, 2020	BUY	$113.31 - $182.44 $7,818 - $12,588	69 Added 0.19%	36,987 $6.14 Million
Q1 2020 May 15, 2020	SELL	$104.32 - $195.28 $327,773 - $613,569	-3,142 Reduced 7.84%	36,918 $4.67 Million
Q4 2019 Feb 13, 2020	BUY	$163.48 - $173.61 $3.35 Million - $3.56 Million	20,522 Added 105.04%	40,060 $6.78 Million
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $119,028 - $132,684	745 Added 3.96%	19,538 $3.28 Million
Q2 2019 Aug 13, 2019	BUY	$144.16 - $172.9 $2.06 Million - $2.48 Million	14,321 Added 320.24%	18,793 $3.25 Million
Q1 2019 May 14, 2019	BUY	$123.7 - $156.3 $123 - $156	1 Added 0.02%	4,472 $684,000
Q4 2018 Feb 15, 2019	BUY	$120.82 - $174.09 $9,423 - $13,579	78 Added 1.78%	4,471 $565,000
Q3 2018 Nov 15, 2018	SELL	$167.67 - $188.27 $50,300 - $56,481	-300 Reduced 6.39%	4,393 $763,000
Q2 2018 Aug 14, 2018	SELL	$160.33 - $189.41 $2.29 Million - $2.71 Million	-14,313 Reduced 75.31%	4,693 $843,000
Q1 2018 May 08, 2018	BUY	$161.53 - $178.11 $188,990 - $208,388	1,170 Added 6.56%	19,006 $3.07 Million
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $20,126 - $22,297	136 Added 0.77%	17,836 $2.85 Million
Q3 2017 Nov 14, 2017	BUY	$149.47 - $160.56 $2.65 Million - $2.84 Million	17,700	17,700 $2.67 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account